Anonymous ID: 8b680a Jan. 7, 2023, 8:13 a.m. No.18097982   🗄️.is đź”—kun

>>18097892

Harry said that while he relayed tales of his adventure and the frostbite to his father King Charles, then still Prince of Wales, and brother William during a pre-wedding celebration, he held back details about his frozen “todger”, saying: “Pa was very interested, and sympathetic about the discomfort of my frost nipped ears and cheeks.”

“While the ears and cheeks were already healing, the todger wasn’t. It was becoming more of an issue by the day,” he claimed.

After the wedding, the prince said that he went to a doctor after using Elizabeth Arden cream to try and heal the genital wound.

The tell-all memoir also, for some reason, apparently reveals that the prince was circumcised as a child, despite rumours to the contrary.

Anonymous ID: 8b680a Jan. 7, 2023, 8:14 a.m. No.18097990   🗄️.is đź”—kun   >>8013

Despite a carefully orchestrated and tightly controlled publicity campaign leading up to the release of his tell-all memoir Spare next week, the contents of Prince Harry’s book have leaked early, revealing some salacious details of the troubled Royal’s life. Among them is the claim he lost his virginity to a horse-riding woman who treated him “like a young stallion” and spanked him on the bottom after they were done.

Anonymous ID: 8b680a Jan. 7, 2023, 8:35 a.m. No.18098131   🗄️.is đź”—kun

https://www.popularmechanics.com/science/a33218172/tesla-patent-curevac-rna-bioreactor-coronavirus/

Tesla Has Been Working On an RNA Bioreactor

The technology could eventually advance a COVID-19 vaccine.

 

Tesla and CureVac have collaborated on a patent for an RNA bioreactor.

Although there are no human vaccines made with RNA, the technology could break through on COVID-19 (coronavirus).

The bioreactor works by combining chemical agents in an egg-shaped magnetic mixer.

Anonymous ID: 8b680a Jan. 7, 2023, 8:36 a.m. No.18098136   🗄️.is đź”—kun

https://electrek.co/2020/07/02/tesla-manufacturing-partner-biotech-firm-curevac-covid-119-vaccine/

Tesla becomes manufacturing partner for biotech firm CureVac working on COVID-19 vaccine

Tesla CEO Elon Musk announced that the automaker has become the manufacturing partner for biotech firm CureVac who is working on a COVID-19 vaccine based on their RNA technology.

CureVac is a Germany-based company developing therapies based on messenger RNA (mRNA), a promising technology to cure a large number of diseases.

Over the last few years, they have been developing novel flu vaccines – making them a frontrunner to come up with a solution for COVID-19.

In May, they published positive results regarding their vaccine candidate:

 

CureVac AG, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimized mRNA, today announced positive pre-clinical results at a low dose for its lead vaccine candidate against the novel Coronavirus (SARS-CoV-2). The data showed a fast induction of a balanced immune response with high levels of virus neutralizing titers (VNTs) and T-cell responses. VNTs are a major criterion supporting that the vaccine candidate has the potential to induce a strong immunologic response to neutralize SARS-CoV-2.

 

A few weeks later, they secured a $300 million investment from the German government.